Despite a tame inflation read, tariff concerns still weigh on investors as the Trump administration's tariff plans will now be litigated in Federal court
Stocks had a strong week on a potential U.S.-China trade deal and cooler inflation data, but volatility may remain as investors shift focus to tax cuts
Even if there is a clear market rotation, these top performing ETFs will have an opportunity to secure gains and move on to be potential trophy winners in 2024.
More than 70% of S&P 500 stocks finished in the red last quarter, but the broad-based selloff may be an opportunity - including for these three biggest losers.
A prudent portfolio strategy can be paring back outperformers and reallocating to less popular, less expensive names - like these three mid-cap tech stocks.
Deere stock has retreated some $60 from its all-time high, but has not been downgraded by any analysts - making the company's latest correction an opportunity.
As the Overstock rebranding buzz turns into a hangover, investors must decide whether or not the recent Bed Bath euphoria goes beyond a short-term rally.
The resilient nature of these three companies — and their current $10 billion-plus cash positions — have been spreading the wealth to investors for decades.
Following a buyout of Chinook Therapeutics, Novartis slipped less than 1%. This speaks to the growth potential of Chinook and ongoing value of Novartis stock.
Bandwagon bulls that flew too close to the SunCar got burned badly, a reminder of how hot new issues can produce huge losses just as easily as huge gains.
Certain sectors like consumer staples and health care tend to outperform during economic turbulence. These three stocks are good names to own for the bad times.